New BÜHLMANN poster about recombinant calprotectin as a promising material to overcome discrepant immunoassays standardizations.
New BÜHLMANN poster about recombinant calprotectin as a promising material to overcome discrepant immunoassays standardizations.
BÜHLMANN presented a poster on Quantum Blue® Infliximab and Adalimumab using capillary blood at this year’s ECCO Congress in Copenhagen.
There is no excerpt because this is a protected post.
Two Quantum Blue® posters about fecal pancreatic elastase and infliximab and adalimumab trough level measurements from capillary blood were presented at the UEG Week 2022.
Social Links